Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination

Reproductive Biology and Endocrinology

Volumn 2, Issue , 2004, Pages

  Mitwally, Mohamed F ^a,b,c   Abdel Razeq, Sonya ^b   Casper, Robert F ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY AT BUFFALO   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

AGE; ANALYSIS OF VARIANCE; ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; INTRAUTERINE INSEMINATION; MALE; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE SUCCESS; RETROSPECTIVE STUDY; SEXUAL INTERCOURSE; TREATMENT OUTCOME; ADULT; ARTIFICIAL INSEMINATION; COITUS; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; TIME;

ADULT; CHORIONIC GONADOTROPIN; COITUS; FEMALE; HUMANS; INSEMINATION, ARTIFICIAL; LUTEINIZING HORMONE; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 4344643365     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-2-55     Document Type: Article

References (40)

1. Allen NC, Herbert CM, Maxson WS, Rogers BJ, Diamond MP, Wentz AC: Intrauterine insemination: a critical review. Fertil Steril 1985, 44:569-580.
2. Guzick D, Carson SA, Coutifaris C, Overstreet JW, Factor-Litvak P, Steinkampf MP, Hill JA, Mastroianni L, Buster JE, Nakajima ST, Vogel DL, Canfield RE: Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999, 340:177-183.
3. Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG: Diagnosis and management of unexplained infertility: an update. Arch Gynecol Obstet 2003, 267(4):177-188.
4. Cohlen BJ, te Velde ER, van Kooij RJ, Looman CW, Habbema JD: Controlled ovarian hyperstimulation and intrauterine insemination for treating male sub-fertility: a controlled study. Hum Reprod 1998, 13:1553-1558.
5. Hughes EG: The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 1997, 12:1865-1872.
6. Burr RW, Siegberg R, Flaherty SP, Wang XJ, Matthews CD: The influence of sperm morphology and the number of motile sperm inseminated on the outcome of intrauterine insemination combined with mild ovarian stimulation. Fertil Steril 1996, 65:127-132.
7. Ombelet W, Vandeput H, Van de Putte G, Cox A, Janssen M, Jacobs P, Bosmans E, Steeno O, Kruger T: Intrauterine insemination after ovarian stimulation with clomiphene citrate: predictive potential of inseminating motile count and sperm morphology. Hum Reprod 1997, 12:1458-1463.
8. Berger T, Marrs RP, Moyer DL: Comparison of techniques for selection of motile spermatozoa. Fertil Steril 1985, 43:268-273.
9. Ransom MX, Blotner MB, Bohrer M, Corsan G, Kemmann E: Does increasing frequency of intrauterine insemination improve pregnancy rates significantly during superovulation cycles? Fertil Steril 1994, 61:303-307.
10. Khalifa Y, Redgment CJ, Tsirigotis M, Grudzinskas JG, Craft IL: The value of single versus repeated insemination in intrauterine donor insemination cycles. Hum Reprod 1995, 10:153-154.
11. Dickey RP, Olar TT, Taylor SN, Curole DN, Rye PH, Matulich EM: Relationship of follicle number, serum estradiol, and other factors to birth rate and multiparity in human menopausal gonadotropin induced intrauterine insemination cycles. Fertil Steril 1991, 56:89-92.
12. Tomlinson MJ, Amissah-Arthur JB, Thompson KA, Kasraie JL, Bentick B: Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success. Hum Reprod 1996, 11:1892-1896.
13. Curie-Cohen M, Luttrell L, Shapiro S: Current practice of artificial insemination by donor in the United States. N Engl J Med 1979, 300:585-590.
14. Federman CA, Dumesic DA, Boone WR, Shapiro SS: Relative efficiency of therapeutic donor insemination using a luteinizing hormone monitor. Fertil Steril 1990, 54:489-492.
15. Pittrof RU, Shaker A, Dean N, Bekir JS, Campbell S, Tan SL: Success of intrauterine insemination using cryopreserved donor sperm is related to the age of the woman and the number of preovulatory follicles. J Assist Reprod Genet 1996, 13:310-314.
16. Manganiello PD, Stern JE, Stukel TA, Crow H, Brinck-Johnsen T, Weiss JE: A comparison of clomiphene citrate and human menopausal gonadotropin for use in conjunction with intrauterine insemination. Fertil Steril 1997, 68:405-412.
17. Martinez AR, Bernadus RE, Voorhorst FJ, Vermeiden JP, Schoemaker J: A controlled study of human chorionic gonadotropin induced ovulation versus urinary luteinizing hormone surge for timing of intrauterine insemination. Hum Reprod 1991, 6:1247-1251.
18. Deaton JL, Clark RR, Pittaway DE, Herbst P, Bauguess P: Clomiphene citrate ovulation induction in combination with a timed intrauterine insemination: the value of urinary luteinizing hormone versus human chorionic gonadotropin timing. Fertil Steril 1997, 68:43-47.
19. Fuh KW, Wang X, Tai A, Wong I, Norman RJ: Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotropin administration and insemination on pregnancy rates. Hum Reprod 1997, 12:2162-2166.
20. Garcia-Velasco JA, Arici A, Zreik TG: Endogenous LH-surge detection versus administration of HCG to correctly time intrauterine insemination: which provides a better pregnancy rate? Hum Reprod 2000, 15(4):975-976.
21. Zawadzki JK, Dunaif A: Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Polycystic ovary syndrome (Edited by: Dunaif A, Givens JR, Haseltine F, Merriam GR). Boston: Blackwell 1992, 377-384.
22. World Health Organization: WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 4 Edition Cambridge University Press, Cambridge, UK 1999.
23. Mitwally MF, Casper RF: Aromatase Inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod Technol 2000, 10:244-247.
24. Mitwally MFM, Casper RF: Aromatase inhibition improves ovarianresponse to follicle-stimulating hormone in poor responders. Fertil Steril 2002, 77(4):776-780.
25. Mitwally MFM, Casper RF: Aromatase inhibitors for the treatment of infertility. Expert Opin Investig Drugs 2003, 12(3):353-371.
26. Macklon NS, Fauser BCJM: Impact of ovarian hyperstimulation on the luteal phase. J Reprod Fertil Suppl 2000, 55:101-108.
27. Sahakyan M, Harlow BL, Hornstein MD: Influence of age, diagnosis, and cycle number on pregnancy rates with gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 1999, 72(3):500-504.
28. Horbay GL, Cowell CA, Casper RF: Multiple follicular recruitment and intrauterine insemination outcomes compared by age and diagnosis. Hum Reprod 1991, 6(7):947-952.
29. World Health Organization: Temporal relationships between ovulation and defined changes in the concentrations of plasma oestradiol-17, luteinizing hormone, follicle-stimulating hormone, and progesterone. Am J Obstet Gynecol 1980, 138:383-390.
30. Garcia JE, Jones GS, Wright GL: Prediction of the time of ovulation. Fertil Steril 1981, 36:308-315.
31. Testart J, Frydman R, Feinstein MC, Thebault A, Roger M, Scholler R: Interpretation of plasma luteinizing hormone assay for the collection of mature oocytes from women: definition of a luteinizing hormone surge-initiation rise. Fertil Steril 1981, 36:50-54.
32. Testart J, Frydman R: Minimum time lapse between luteinizing hormone surge or human chorionic gonadotropin administration and follicular rupture. Fertil Steril 1982, 37:50-53.
33. Martinez AR, Bernardus RE, Voorhorst FJ, Vermeiden JP, Schoemaker J: Pregnancy rates after timed intercourse or intrauterine insemination after human menopausal gonadotropin stimulation of normal ovulatory cycles: a controlled study. Fertil Steril 1991, 55:258-265.
34. Casper RF, Erskine HJ, Armstrong DT, Brown SE, Daniel SA, Graves GR, Yuzpe AA: In vitro fertilization: diurnal and seasonal variation in luteinizing hormone surge onset and pregnancy rates. Fertil Steril 1988, 49(4):644-648.
35. Cohlen BJ, te Velde ER, Scheffer G, van Kooij RJ, Maria de Brouwer CP, van Zonneveld P: The pattern of the luteinizing hormone surge in spontaneous cycles is related to the probability of conception. Fertil Steril 1993, 60:413-417.
36. Awonuga A, Govindbhai J: Is waiting for an endogenous luteinizing hormone surge and/or administration of human chorionic gonadotropin of benefit in intrauterine insemination? Hum Reprod 1999, 14(7):1765-17670.
37. Arici A, Carr BR, Byrd W: Comparison of two LH monitoring methods in women undergoing intrauterine insemination. In Proceedings of the 48th Annual Meeting of the American Fertility Society. San Antonio, TXS70.
38. Lloyd R, Coulman CB: The accuracy of urinary luteinizing hormone testing in predicting ovulation. Am J Obstet Gynecol 1989, 160:1370-1372.
39. Irons DW, Singh MM: Evaluation of transvaginal sonography combined with a urinary luteinizing hormone monitor in timing donor insemination. Hum Reprod 1994, 9:1859-1862.
40. Zreik TG, Garcia-Velasco JA, Habbossh MS, Olive DL, Arici A: Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles. Fertil Steril 1999, 71:1070-1074.